Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
Ratings
Positive Outlook for Alnylam Pharma Amid Promising Cardiovascular Drug Developments and Strategic Partnerships
11h ago
ALNY
Premium
The Fly
Alnylam reports new data from HELIOS-B Phase 3 study
13h ago
ALNY
Premium
The Fly
Roche, Alnylam to initiate Phase 3 cardiovascular outcomes trial of zilebesiran
2d ago
ALNY
CHRO
Premium
The Fly
Alnylam price target raised to $570 from $500 at H.C. Wainwright
26d ago
ALNY
Premium
Ratings
Alnylam Pharma: Strong Commercial Performance and Promising Pipeline Drive Buy Rating
26d ago
ALNY
Premium
Ratings
Alnylam Pharma: Strong Growth Prospects and Transition to Profitability Support Buy Rating
26d ago
ALNY
Premium
The Fly
Alnylam price target raised to $475 from $348 at JPMorgan
27d ago
ALNY
Premium
The Fly
Coinbase downgraded, Spotify upgraded: Wall Street’s top analyst calls
29d ago
AVB
BAX
Premium
The Fly
Alnylam upgraded to Peer Perform from Underperform at Wolfe Research
29d ago
ALNY
Premium
The Fly
Oppenheimer upgrades Alnylam to Outperform on Amvuttra launch
29d ago
ALNY
Premium
The Fly
Alnylam upgraded to Outperform from Perform at Oppenheimer
29d ago
ALNY
Premium
Ratings
Alnylam Pharma: Hold Rating Amid Strong Sales and Elevated Costs
29d ago
ALNY
Premium
Company Announcements
Alnylam’s Q2 2025 Earnings Call Highlights Robust Growth
1M ago
ALNY
Premium
The Fly
Alnylam price target raised to $459 from $385 at Truist
1M ago
ALNY
Premium
The Fly
Alnylam price target raised to $450 from $342 at Scotiabank
1M ago
ALNY
Premium
The Fly
Alnylam price target raised to $424 from $370 at Raymond James
1M ago
ALNY
Premium
The Fly
Alnylam price target raised to $449 from $304 at Piper Sandler
1M ago
ALNY
Premium
The Fly
Alnylam price target raised to $550 from $403 at UBS
1M ago
ALNY
Premium
The Fly
Alnylam price target raised to $415 from $390 at Canaccord
1M ago
ALNY
Premium
Ratings
Alnylam Pharma: Strong Financials and Strategic Advancements Drive Buy Rating
1M ago
ALNY
Premium
The Fly
Alnylam price target raised to $405 from $312 at Morgan Stanley
1M ago
ALNY
Premium
Ratings
Cautious Optimism: Alnylam Pharma’s Strong TTR Franchise Growth and Hold Rating
1M ago
ALNY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
